Efficacy and safety assessment
tumor
SECONDARY, TUMOR
The primary endpoint was ORR accessed by the RECIST criteria. The secondary endpoints were MPR rate (proportion of patients with no more than 10% residual viable tumor cells), pCR rate (proportion of patients without residual viable tumor cell)In addition, some participants refused or failed to fill in the health-related life quality questionnaires as required due to personal reasons or privacy issues, which affected the data quality of this part. In this case, the analysis of the predefined health-related quality of life questionnaires was abandoned in this report.